Alzinova AB Share Price

Equities

ALZ

SE0007413455

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 07:33:08 29/04/2024 pm IST 5-day change 1st Jan Change
1.168 SEK +1.04% Intraday chart for Alzinova AB -37.61% -61.52%

Financials

Sales 2023 270K 24.69K 2.06M Sales 2024 * 51.5M 4.71M 393M Capitalization 51.48M 4.71M 393M
Net income 2023 -16M -1.46M -122M Net income 2024 * 6M 549K 45.79M EV / Sales 2023 419 x
Net cash position 2023 22.03M 2.01M 168M Net cash position 2024 * 69.1M 6.32M 527M EV / Sales 2024 * -0.34 x
P/E ratio 2023
-7.4 x
P/E ratio 2024 *
11.6 x
Employees 4
Yield 2023 *
-
Yield 2024 *
-
Free-Float 63.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.04%
1 week-37.61%
Current month-36.73%
1 month-36.17%
3 months-55.92%
6 months-52.71%
Current year-61.52%
More quotes
1 week
1.01
Extreme 1.006
1.90
1 month
1.01
Extreme 1.006
2.15
Current year
1.01
Extreme 1.006
3.20
1 year
1.01
Extreme 1.006
3.92
3 years
0.98
Extreme 0.98
12.00
5 years
0.98
Extreme 0.98
19.80
10 years
0.98
Extreme 0.98
44.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 16/19/16
Founder 52 17/11/17
Chief Tech/Sci/R&D Officer - 14/23/14
Members of the board TitleAgeSince
Director/Board Member 67 01/18/01
Director/Board Member 68 01/20/01
Chairman 59 01/23/01
More insiders
Date Price Change Volume
29/24/29 1.168 +1.04% 164 502
26/24/26 1.156 -32.00% 1,225,606
25/24/25 1.7 -2.86% 125,626
24/24/24 1.75 -4.58% 222,480
23/24/23 1.834 -2.03% 76,831

Delayed Quote Nasdaq Stockholm, April 29, 2024 at 07:33 pm IST

More quotes
Alzinova AB is a Sweden-based company, which is primarily involved in the biotechnology industry. The Company is engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease. The Company focuses on development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric Aβ that damages brain synapses.
More about the company

Annual profits - Rate of surprise